Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma
- 作者Yoshikawa, D; Ojima, H; Kokubu, A; Ochiya, T; Kasai, S; Hirohashi, S; Shibata, T
- 卷第100卷
- 期第8期
- 印刷ISSN0007-0920
- 电子ISSN1532-1827
- 文件大小421.67KB
- 发表时间2009
- DOI10.1038/sj.bjc.6604988
- 页码1257-1266